• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 178
  • 83
  • 43
  • 19
  • 15
  • 13
  • 13
  • 13
  • 7
  • 6
  • 5
  • 4
  • 3
  • 3
  • 2
  • Tagged with
  • 450
  • 450
  • 98
  • 82
  • 81
  • 79
  • 67
  • 60
  • 49
  • 44
  • 41
  • 40
  • 39
  • 37
  • 31
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
31

Internal research & development markets

Kasper, Eric. January 1900 (has links)
Thesis (Ph.D.)--Metropolitan University, Leeds. / Includes bibliographical references.
32

Endogenous R&D, R&D cooperation, and mode of foreign expansion

Tongrut, Ruttaya. January 2004 (has links)
Thesis (Ph. D.)--University of Missouri-Columbia, 2004. / Typescript. Includes bibliographical references (leaves 175-178). Also available on the Internet.
33

Endogenous R&D, R&D cooperation, and mode of foreign expansion /

Tongrut, Ruttaya. January 2004 (has links)
Thesis (Ph. D.)--University of Missouri-Columbia, 2004. / Typescript. Includes bibliographical references (leaves 175-178). Also available on the Internet.
34

Diagnóstico y programación de la Finca Sabana Grande

Monterroso Salvatierra, Neptali. January 1969 (has links)
Tesis (Licenciado en Ciencias Agrícolas): Universidad de San Carlos, Facultad de Agronomía, 1969. / eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references.
35

Internal research & development markets

Kasper, Eric. January 1900 (has links)
Thesis (Ph.D.)--Metropolitan University, Leeds. / Includes bibliographical references.
36

Internal research & development markets

Kasper, Eric. January 1900 (has links)
Thesis (Ph.D.)--Metropolitan University, Leeds. / Includes bibliographical references.
37

Internal research & development markets

Kasper, Eric. January 1900 (has links)
Thesis (Ph. D.)--Metropolitan University, Leeds. / Description based on print version record. Includes bibliographical references.
38

Investment, R & D, and the financing decisions of the firm

Kruiniger, Hugo. January 1996 (has links)
Proefschrift Rijksuniversiteit Limburg, Maastricht. / Met samenvatting in het Nederlands. - Met lit. opg.
39

The "image" of science and the scientist as conceived by an employee public in a research and development organization

Nalesnik, Richard Peter January 1963 (has links)
Thesis (M.S.)--Boston University
40

Decision-Making Associated with Drug Candidates in the Research and Development (R&D) Pipeline

Sarnowski, Jeff J. January 2006 (has links)
Class of 2006 Abstract / Objectives: To investigate the types of information and resources either used or required for the management of products in the pipeline as perceived by decision-makers in the biotechnology and pharmaceutical (B&P) industries. More specifically, the objectives are to ascertain the strategic use of pharmacoeconomic (PE), financial, and decision- making tools and financing requirements amongst pipeline candidates. Methods: A study-specific survey instrument was used for the project. In detail, this survey is based upon the use of financial, PE, and decision-making tools for drug product development. Approximately 396 B&P firms were surveyed via postal mail, wherein the primary contact was the Chief Financial Officer (CFO). If the CFO was not listed on the firm’s website, the survey will be addressed to the Business and Development Officer (BDO) or Chief Executive Officer (CEO). The companies’ information will be identified by use of publicly-available databases. A modified form of a total survey design will be used for the postal mailings, including one initial mailing with a cover letter and survey, a follow-up reminder postcard, a second cover letter and survey for non-responders, and a final follow-up reminder postcard then after. Results: Survey instruments were completed by 20 firms, with 5 of them from public firms and 15 from the private sector. Capital and regulatory requirements and investor expectations are the most important factors considered during early and late phase clinical trials. Net present value (NPV) and internal rate of return (IRR) are the most commonly used financial analytic tools used for making research and development (R&D) decisions. PE are reported to be first used during all clinical phases prior to Food and Drug Administration (FDA) approval, and most drug candidates undergo formal PE evaluations. PE is also used in various areas of R&D and marketing components, such as licensing and go/no-go decisions. Capital/securities markets and venture capital (VC) are the primary sources of capital used in the development of a new drug. VC is important during all phases of R&D and numerous VC firms get involved. B&P firms disagree that VC companies should be involved with the managerial roles of the firm. Conclusions: It has been determined that the strategic use of PE, financial and decision-making tools, and capital requirements amongst pipeline candidates are important during all phases of R&D.

Page generated in 0.14 seconds